Neuralstem Receives Approval To Commence First ALS Stem Cell Trial At Emory ALS Center
Links shared publicly online about this topic.
- 1,519total visits
Neuralstem Receives Approval To Commence First ALS Stem Cell Trial At Emory ALS Center
Neuralstem, Inc. (NYSE Amex: CUR) announced that its Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells has been approved by the Ins
View full resource at medicalnewstoday.com
Tags: ALS, Disease and Condition, Stem Cell
Most Recently Shared on December 19, 2009 at 11:05 am By:
Neuralstem Receives Approval To Commence First ALS Stem Cell Trial At Emory ALS Center http://mnt.to/3vHH
Also Shared By:
Advertisement
MNT Clinical Trials
@mnt_clinical
Neuralstem Receives Approval To Commence First ALS Stem Cell Trial At Emory ALS Center http://mnt.to/3vHH
1 year ago...